THE DUBERSTEIN GROUP INC. for PHRMA INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
IPAB Disapproval Resolution: -S.260 (Cornyn) - Protecting Seniors' Access to Medicare Act of 2017. -HJ Res. 51 (Roe/Ruiz) - Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act. -H.R.849 (Roe) - Protecting Seniors' Access to Medicare Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELLIOTT BRADBURY | — |
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
Health Issues HCR
Health Care Reform: H.R.1628 - Better Care Reconciliation Act of 2017. Drug Re-importation: S.469 (Sanders) - Affordable and Safe Prescription Drug Importation Act, H.R.1301 - Department of Defense Appropriations Act, 2017. Prescription Drug User Fee Act (PDUFA) - H.R.2430 - FDA Reauthorization Act of 2017 Children's Health Insurance Program. Drug Pricing: H.R.1301 - Department of Defense Appropriations Act, 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELLIOTT BRADBURY | — |
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
| ANNE WALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.